Taking Stock After Gene Patents Are Invalidated
Tuesday, March 30, 2010 - 23:07
in Mathematics & Economics
Many biotechnology stocks fell as investors struggled to understand the impact of a ruling that threw out parts of two gene patents and called into question thousands more.